Godlike Productions - Discussion Forum
Users Online Now: 1,382 (Who's On?)Visitors Today: 233,630
Pageviews Today: 379,183Threads Today: 143Posts Today: 2,505
04:03 AM


Back to Forum
Back to Forum
Back to Thread
Back to Thread
REPORT ABUSIVE REPLY
Message Subject Bill Gates - CoVid Vaccines have Severe Side Effects
Poster Handle Anonymous Coward
Post Content
Thread: Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
01/10/2021 08:21 AM

=========================
WARNING - WARNING - WARNING

Thread: Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the

SARS Virus
01/10/2021 08:21 AM

[link to journals.plos.org (secure)]

Immunization with SARS Coronavirus Vaccines Leads to
Pulmonary Immunopathology on Challenge with the SARS
Virus
Chien-Te Tseng,Elena Sbrana,Naoko Iwata-Yoshikawa,Patrick C. Newman,Tania Garron,Robert L. Atmar,Clarence J. Peters,Robert B. Couch

Results
All vaccines induced serum neutralizing antibody with
increasing dosages and/or alum significantly increasing
responses. Significant reductions of SARS-CoV two
days after challenge was seen for all vaccines and prior
live SARS-CoV. All mice exhibited histopathologic
changes in lungs two days after challenge
including all animals vaccinated (Balb/C and C57BL/6) or
given live virus, influenza vaccine, or PBS

suggesting infection occurred in all.

Histopathology seen in animals given one of the SARS-CoV
vaccines was uniformly a Th2-type immunopathology with
prominent eosinophil infiltration, confirmed
with special eosinophil stains. The pathologic changes
seen in all control groups lacked the eosinophil
prominence.

Conclusions
These SARS-CoV vaccines all induced antibody and
protection against infection with SARS-CoV. However,
challenge of mice given any of the vaccines led to
occurrence of Th2-type immunopathology suggesting
hypersensitivity to SARS-CoV
components was induced. Caution in proceeding to
application of a SARS-CoV vaccine in humans is indicated.


- - - - - -
notice the FLU Vaccine may cause this reaction.

histopathologic changes in lungs two days after challenge
including all animals vaccinated (Balb/C and C57BL/6) or
given live virus, influenza vaccine, or PBS
suggesting infection occurred in all.

- - - - -- -
To put it short at bluntly:
CoVid Vac Leads to Lung Disease on Challenge with the
SARS Virus and the Flu Vaccine increases this Reaction.
 
Please verify you're human:




Reason for reporting:







GLP